Herbal cream of borage, evening primrose, calendula, and leek versus topical mometasone 0.01% for atopic dermatitis

Phase 3

Recruiting

• Conditions: Atopic dermatitis.; Atopic dermatitis

• Registration Number: IRCT20211216053428N1
• Lead Sponsor: Vice chancellery of Research and Technology, Isfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 8 March 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 62

Inclusion Criteria

Age >7 years
SCORAD score <50

Exclusion Criteria

Accompanying physical illness
Any physical illness preventing drug administration
Treatment in the past 6 months
Drug use or alcohol consumption in the past 6 months
Pregnancy or lactation
Lack of following up by the patient
Severe drug hypersensitivity

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement in SCORing Atopic Dermatitis (SCORAD). Timepoint: Weeks 0, 4, 8, and 12. Method of measurement: SCORing Atopic Dermatitis (SCORAD).

Secondary Outcome Measures

Name	Time	Method
Patient satisfaction with treatment. Timepoint: Weeks 4, 8, and 16. Method of measurement: 10-item visual analogue scale (VAS).